Sign in

CIK 0001665988

  • Accelerated filer
  • Emerging growth company

Bioventus Inc.

Sign in to watch
Ticker
BVS
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
810980861
Phone
+1 919-474-6700
Business address
4721 EMPEROR BOULEVARD, SUITE 100, DURHAM, NC, 27703
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-02-14 Anglum Gregory O. SVP & CFO Sale −1,294 $11.99 $16K 55,013
2022-02-11 Anglum Gregory O. SVP & CFO Exercise or conversion +4,400 56,307
2022-02-11 Anglum Gregory O. SVP & CFO Exercise or conversion · Restricted Stock Units −4,400 0
2022-02-10 Anglum Gregory O. SVP & CFO Exercise or conversion +65,581 71,581
2022-02-10 Anglum Gregory O. SVP & CFO Shares withheld for taxes +19,674 $12.88 $253K 51,907
2022-02-10 Anglum Gregory O. SVP & CFO Exercise or conversion · Phantom Profit Units −65,581 0
2021-04-01 Anglum Gregory O. SVP & General Counsel Grant or award · Restricted Stock Units +96,876 96,876
2021-04-01 Anglum Gregory O. SVP & General Counsel Grant or award · Stock Options +9,100 9,100
2021-02-11 Anglum Gregory O. SVP & General Counsel Purchase +6,000 $13.00 $78K 6,000
2021-02-11 Anglum Gregory O. SVP and CFO Grant or award · Restricted Stock Units +4,400 4,400

Page 1 of 1 · 10 trades